Rhonda Farnum - 28 Feb 2022 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, COMM & MEDICAL AFFAIRS
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
28 Feb 2022
Net transactions value
-$23,947
Form type
4
Filing time
02 Mar 2022, 18:08:19 UTC
Previous filing
23 Feb 2022
Next filing
24 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Sale $23,947 -2,356 -0.7% $10.16 333,271 28 Feb 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 5/17/21.
F2 This transaction was executed in multiple trades at prices from $10.02 to $10.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.